Exclude Patient Type Detail Header
No
Footnote
<sup>4</sup> Other FDA-approved options not included in RCTs: <b>atorvastatin</b> 20 mg, <b>rosuvastatin</b> 5 mg, <b>pravastatin</b> 80 mg, <b>fluvastatin</b> XL 80 mg, <b>pitavastatin</b> 2-4 mg. Although <b>simvastatin</b> 80 mg was studied, this dose is not FDA-recommended d/t myopathy risk.
Detail Type
Text